Clinical trial Recruiting at 1 site Observational Ages 18 and up

Clareon TruPlus vs Tecnis Eyhance IOLs for cataract surgery

Official title: Visual and Patient Reported Outcomes Comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in Normal Cataract Patients: Stage 1

Run by Gainesville Eye Associates · NCT07658040 · Data updated 2026-11-12

This study compares two types of intraocular lenses implanted in both eyes of adults with cataracts to see which provides better vision after three months.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorGainesville Eye Associates
Academic / other
Locations1 site (Gainesville, Georgia)
StatusRecruiting
StartedJuly 20, 2026
Main results expectedAugust 9, 2027
Study endsAugust 9, 2027
Registry record updatedSeptember 1, 2026
Trial IDNCT07658040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with bilateral age-related cataracts planning simultaneous bilateral cataract surgery and meeting strict vision and astigmatism criteria.

Probably not a fit

Patients with irregular corneas, macular or retinal diseases, glaucoma, severe dry eye, or other conditions not compatible with the study criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, two-arm, single-center, single-surgeon study that doubles-masks both participants and assessors. Participants will undergo bilateral cataract removal with implantation of either Clareon TruPlus IOL or Tecnis Eyhance IOL, followed by a 3-month postoperative assessment. The study collects pre-operative and postoperative data to compare outcomes related to vision and refractive results. It will be conducted at one site with a single surgeon to minimize variability. Key eligibility requires bilateral cataracts, acceptable expected postoperative visual acuity, and residual astigmatism within target ranges.

Why it matters

Potential benefit: If successful, patients may experience improved postoperative visual outcomes with one of the IOL options, potentially guiding lens choice for future surgeries.

How similar studies have gone: Prior studies with similar IOL comparisons have shown variable but informative results; this design’s double-masked approach aims to reduce bias, though direct, large-scale replication is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing and able to understand and sign informed consent.
* Adult patient diagnosed with age-related cataracts bilaterally.
* Planned bilateral cataract removal and with bilateral implantation of the Clareon TruPlus IOL/Toric BLF (T3-T5) or Tecnis Eyhance IOL/Eyhance Toric (equivalent to T3-T5).
* Best monocular corrected distance visual acuity expected to be 0.1 logMAR (Snellen 20/25) or better in both eyes postoperatively as determined by surgeon.
* Residual astigmatism expected to be \<= 0.50 diopters in both eyes postoperatively as determined by surgeon (After using either toric IOL or arcuate incision with laser or manual LRI).
* Normal ocular findings aside from cataract.

Exclusion Criteria:

* Moderate-severe corneal pathology, irregular astigmatism, preexisting macular disease and other retinal degenerative diseases expected to cause future vision loss, glaucoma, severe dry eye disease, nystagmus, strabismus, zonular laxity or dehiscence, pseudoexfoliation.
* Previous history of any ocular surgery including corneal refractive surgery.
* History of amblyopia or monofixation syndrome with poor stereoscopic vision.
* Participants desiring monovision.
* Any planned simultaneous/combined procedures at time of cataract surgery (e.g. MIGs).
* Participation in another clinical study that could interfere with the results.
* Any active ocular infection or inflammation.

Where it's running

  • North Georgia Eye Associates
    Gainesville, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.